Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis

Abstract

Currently several tyrosine kinase inhibitors (TKIs) are approved for treatment of chronic myeloid leukemia (CML). Our goal was to identify the optimal sequential treatment strategy in terms of effectiveness and cost-effectiveness for CML patients within the US health care context. We evaluated 18 treatment strategies regarding survival, quality-adjusted… (More)
DOI: 10.1155/2015/982395

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Rochau2015EffectivenessAC, title={Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis}, author={Ursula Rochau and Martina Kluibenschaedl and David D. Stenehjem and Kuo Kuan-Ling and Jerald P Radich and Gary M. Oderda and Diana I. Brixner and Uwe Siebert}, booktitle={Leukemia research and treatment}, year={2015} }